Inventor
VITALE LAURA A
US15 patents
⚠️ This page may combine multiple inventors who share the name “VITALE LAURA A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLDEX THERAPEUTICS INC
9 patentsUS10633444B2Apr 28, 2020
Agonistic antibodies that bind CD40
CELLDEX THERAPEUTICS INC12 citations91
US11180566B2Nov 23, 2021
Antibodies that bind human CD27 and uses thereof
CELLDEX THERAPEUTICS INC4 citations71
US10941201B2Mar 9, 2021
Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies
CELLDEX THERAPEUTICS INC2 citations70
US10865244B2Dec 15, 2020
Nucleic acids encoding agonistic antibodies that bind CD40
CELLDEX THERAPEUTICS INC1 citations70
US11459393B2Oct 4, 2022
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
CELLDEX THERAPEUTICS INC0 citations62
US11332537B2May 17, 2022
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
CELLDEX THERAPEUTICS INC1 citations62
US8362214B2Jan 29, 2013
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
CELLDEX THERAPEUTICS INC3 citations61
US12297266B2May 13, 2025
Agonistic antibodies that bind human CD40 and uses thereof
CELLDEX THERAPEUTICS INC0 citations60
US9624300B2Apr 18, 2017
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
CELLDEX THERAPEUTICS INC0 citations51
KELER TIBOR
5 patentsUS9169325B2Oct 27, 2015
Antibodies that bind human CD27 and uses thereof
KELER TIBOR64 citations96
US8236318B2Aug 7, 2012
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
KELER TIBOR17 citations91
US8318165B2Nov 27, 2012
Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (MCSP)
KELER TIBOR2 citations62
US8586720B2Nov 19, 2013
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
KELER TIBOR3 citations61
US8404820B2Mar 26, 2013
Human monoclonal antibodies against Bacillus anthracis protective antigen
KELER TIBOR0 citations50